Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eusebio Chiefari

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Journal of Clinical Medicine|September 14, 2024
Clinical Risk Factors and First Gestational 75 g OGTT May Predict Recurrent and New-Onset Gestational Diabetes in Multiparous WomenMaria Mirabelli, Vera Tocci, Eusebio Chiefari, et al.
Endocrine|January 13, 2024
Incidental thyroid carcinoma in an endemic goiter area in Italy: histopathological features and predictors of a common findingEusebio Chiefari, Nadia Innaro, Rita Gervasi, et al.
Minerva Endocrinology|February 1, 2022
Predicting the response to SGLT-2 inhibitors as add-on therapy to multiple day injection insulin with glycated albumin: a pilot studyStefano Iuliano, Emanuela A Greco, Maria Mirabelli, et al.
Journal of Diabetes Research|November 30, 2019
Long-Term Effectiveness and Safety of SGLT-2 Inhibitors in an Italian Cohort of Patients with Type 2 Diabetes MellitusMaria Mirabelli, Eusebio Chiefari, Patrizia Caroleo, et al.
Journal of Diabetes Research|October 5, 2020
Appropriate Timing of Gestational Diabetes Mellitus Diagnosis in Medium- and Low-Risk Women: Effectiveness of the Italian NHS Recommendations in Preventing Fetal MacrosomiaPaola Quaresima, Federica Visconti, Eusebio Chiefari, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2023
Metformin in Gestational Diabetes Mellitus: To Use or Not to Use, That Is the QuestionVera Tocci, Maria Mirabelli, Alessandro Salatino, et al.
Journal of Clinical Medicine|April 28, 2023
Maternal Preconception Body Mass Index Overtakes Age as a Risk Factor for Gestational Diabetes MellitusMaria Mirabelli, Vera Tocci, Alessandra Donnici, et al.
World Journal of Diabetes|October 10, 2017
Expression of matrix metalloproteinase-11 is increased under conditions of insulin resistanceBiagio Arcidiacono, Eusebio Chiefari, Anna Elisa Laria, et al.
International Journal of Environmental Research and Public Health|October 2, 2019
First Trimester Combined Test (FTCT) as a Predictor of Gestational Diabetes MellitusFederica Visconti, Paola Quaresima, Eusebio Chiefari, et al.
Journal of Clinical Medicine|April 3, 2021
Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 DiabetesMaria Mirabelli, Eusebio Chiefari, Vera Tocci, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|September 14, 2024
Clinical Risk Factors and First Gestational 75 g OGTT May Predict Recurrent and New-Onset Gestational Diabetes in Multiparous WomenMaria Mirabelli, Vera Tocci, Eusebio Chiefari, et al.
Endocrine|January 13, 2024
Incidental thyroid carcinoma in an endemic goiter area in Italy: histopathological features and predictors of a common findingEusebio Chiefari, Nadia Innaro, Rita Gervasi, et al.
Minerva Endocrinology|February 1, 2022
Predicting the response to SGLT-2 inhibitors as add-on therapy to multiple day injection insulin with glycated albumin: a pilot studyStefano Iuliano, Emanuela A Greco, Maria Mirabelli, et al.
Journal of Diabetes Research|November 30, 2019
Long-Term Effectiveness and Safety of SGLT-2 Inhibitors in an Italian Cohort of Patients with Type 2 Diabetes MellitusMaria Mirabelli, Eusebio Chiefari, Patrizia Caroleo, et al.
Journal of Diabetes Research|October 5, 2020
Appropriate Timing of Gestational Diabetes Mellitus Diagnosis in Medium- and Low-Risk Women: Effectiveness of the Italian NHS Recommendations in Preventing Fetal MacrosomiaPaola Quaresima, Federica Visconti, Eusebio Chiefari, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2023
Metformin in Gestational Diabetes Mellitus: To Use or Not to Use, That Is the QuestionVera Tocci, Maria Mirabelli, Alessandro Salatino, et al.
Journal of Clinical Medicine|April 28, 2023
Maternal Preconception Body Mass Index Overtakes Age as a Risk Factor for Gestational Diabetes MellitusMaria Mirabelli, Vera Tocci, Alessandra Donnici, et al.
World Journal of Diabetes|October 10, 2017
Expression of matrix metalloproteinase-11 is increased under conditions of insulin resistanceBiagio Arcidiacono, Eusebio Chiefari, Anna Elisa Laria, et al.
International Journal of Environmental Research and Public Health|October 2, 2019
First Trimester Combined Test (FTCT) as a Predictor of Gestational Diabetes MellitusFederica Visconti, Paola Quaresima, Eusebio Chiefari, et al.
Journal of Clinical Medicine|April 3, 2021
Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 DiabetesMaria Mirabelli, Eusebio Chiefari, Vera Tocci, et al.
Pageof 8